Yongin, South Korea

As a core research center built on Daewoong’s differentiated technological capabilities and unique open collaboration model, the Daewoong Pharmaceutical Research Center drives the development of groundbreaking medicines—ranging from innovative small-molecule drugs and biopharmaceuticals to biosimilars and advanced cell and gene therapies—that contribute to improving the quality of life worldwide.

• 72 Dugye-ro, Pogok-eup, Cheoin-gu, Yongin-si, Gyeonggi-do, South Korea

• 031-270-8421

• 031-322-7152

Hyangnam, South Korea

The research center possesses advanced expertise in large-scale oxidation–reduction technologies and enzyme-based biocatalytic synthesis platforms. Building on these capabilities, the research center drives innovation in active pharmaceutical ingredient (API) development, enhances raw material manufacturing efficiency through process validation, and ensures a robust and reliable commercial supply system.

• 29 Je-yakdanji-ro, Hyangnam-eup, Hwaseong-si, Gyeonggi-do (Hagil-ri 1404-1), South Korea

• 031-371-6003

• 031-353-5626

Yongin, South Korea

Leveraging formulation technology to enhance generics and develop value-added medicines, thereby securing differentiated product competitiveness. Managing the end-to-end development process, from formulation design to technology transfer and commercialization, to ensure stable market entry and optimal product quality.

• 72 Dugye-ro, Pogok-eup, Cheoin-gu, Yongin-si, Gyeonggi-do, South Korea

Suwon, South Korea

Leads development of innovative biologics—from discovery and development to process optimization and clinical approval—grounded in a systematic research strategy and years of accumulated R&D expertise.

• 10th Floor, Gyeonggi Bio Center, 145 Gwanggyo-ro, Suwon-si, Gyeonggi-do, South Korea

• +82-31-888-6521

• +82-31-888-6523

Daejeon, South Korea

The research center possesses advanced expertise in large-scale oxidation–reduction technologies and enzyme-based biocatalytic synthesis platforms. Building on these capabilities, the research center drives innovation in active pharmaceutical ingredient (API) development, enhances raw material manufacturing efficiency through process validation, and ensures a robust and reliable commercial supply system.

• Room 208, Migeon Techno World, 199 Techno 2-ro, Yuseong-gu, Daejeon, South Korea

• +82-42-867-2042~4

• +82-42-867-2045

Hyangnam, South Korea

Producing botulinum toxin products based on world-class quality and technological excellence.

• 35-14, Je-yakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do (Sangsin-ri), South Korea

• 010-3322-4600

• hklee028@daewoong.co.kr

Hyangnam, South Korea

Producing high-quality solid, nasal, and dual-chamber liquid pharmaceuticals with world-class manufacturing standards.

• 35-14, Je-yakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do (Sangsin-ri), South Korea

• 031-350-8740

• 031-350-8899

Hyangnam, South Korea

Stably producing high-quality active pharmaceutical ingredients such as UDCA and Fexuprazan, while serving as a strategic partner through CDMO services.

• 29 Je-yakdanji-ro, Hyangnam-eup, Hwaseong-si, Gyeonggi-do (Hagil-ri 1404-1), South Korea

• 031-353-5271

• 031-353-5626

Hyangnam, South Korea

A Contract Manufacturing Organization (CMO) specializing in microbial-based biopharmaceuticals, providing global-standard end-to-end services from Drug Substance (DS) to Drug Product (DP) commercial manufacturing at our state-of-the-art facility.

• 031-690-9204

• 031-690-9219

Osong, South Korea

This is Daewoong Pharmaceutical’s main production site, where high-quality pharmaceuticals—such as sustained-release injectables, new oral solid drugs, and generic oral solid drugs —are manufactured under a cGMP-level quality management system.

• 1 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, South Korea

• 043-249-2777

• 043-249-2935

Anseong, South Korea

We manufacture Gliatamine, BeaCept, BeaZaltan, V-Posi, Fosidapa, Cratin, Clopidogrel, and Atorvastatin.

• 69 Gongdan 1-ro, Anseong-si, Gyeonggi-do (Singeonji-dong), South Korea

• 031-678-1800

• 031-678-1849

Seongnam, South Korea

This is the new Cefapime plant established to strengthen competitiveness in the antibiotic sector. By expanding production capacity, it addresses medicine shortages and growing demand, while producing high-quality products through dedicated CMO lines and optimized quality systems.

• 57 Je-yakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, South Korea

• 031-359-3114

• 031-359-3197

Daejeon, South Korea

This manufacturing hub produces specialty drugs, including prescription medicines and hair loss treatments. It ensures the stable supply of high-quality pharmaceuticals through strict quality control and GMP-compliant production systems.

• 43 Sangseodang 1-gil, Daedeok-gu, Daejeon, South Korea

• +82-42-932-5997~9

• +82-42-932-6427